AGM/EGM31 Jul 2026, 10:10 pm
Astec Lifesciences Holds 32nd AGM, Approves FY26 Annual Report
AI Summary
Astec Lifesciences Limited successfully conducted its 32nd Annual General Meeting (AGM) on July 31, 2026, via Video Conferencing. The meeting, held in compliance with MCA and SEBI regulations, saw the adoption of the Annual Report for the Financial Year 2025-26. Shareholders also voted on resolutions including the adoption of financial statements and the re-appointment of a director. The company provided remote e-voting facilities and allowed e-voting during the AGM. The proceedings included a welcome by the Company Secretary, a speech by the Chairperson, and attendance by directors and auditors.
Key Highlights
- 32nd AGM held on July 31, 2026, via VC/OAVM.
- Annual Report for FY 2025-26 approved by shareholders.
- Director re-appointment and financial statements adopted.
- Remote e-voting and in-meeting e-voting facilities provided.
- Voting results to be declared within two working days.
Price Impact
More from ASTEC